The data revealed that the use of the Trans-Arterial Micro-Perfusion (TAMP) device resulted in greater drug potency and fewer ...

Purpose: The frequency of drug administration errors and incompatibilities between intravenous drugs before and after an intervention in an intensive care unit (ICU) is discussed. Methods ...

BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's Supplemental Biologics License Application ...

The Food and Drug Administration said Tuesday that no IV glutathione product in the Philippines was approved for skin whitening.

Biogen and Eisai have won Food and Drug Administration approval of an intravenous maintenance dosing of their Leqembi drug for early Alzheimer's disease. The companies late Sunday said the FDA ...

Why would an alternative to intravenous access be sought for drug administration in cases of out-of-hospital cardiac arrest? Previous trials have explored the clinical effectiveness of medications ...

in part because its administration is time-consuming and it requires regular MRIs and screenings. Patients can switch to a monthly dose after having received an intravenous infusion of the drug ...

Biogen BIIB announced that the FDA has approved a monthly maintenance dosing version for its intravenously (IV) administered ...

Trump continues his crackdown on illegal immigration and takes executive action on federal aid and DEI initiatives.

The Hochul administration wants to cancel using the ... of law by replacing `an addict or a habitual user of any narcotic drug’ with ‘a person with a substance use disorder,'” a budget ...

The task force defined 4 overarching principles and 11 points to consider for use of antirheumatic drugs during pregnancy and lactation. Compatibility with pregnancy and lactation was found for ...